NSDL IPO allotment was finalized on August 4, 2025 after ₹4,011 crore OFS was subscribed 41×. Check your share allocation via Link Intime (Registrar), BSE, or NSE. GMP trades near ₹124 (~15% upside), listing expected on August 6.
📅 NSDL IPO Allotment Status — Key Updates Today
The highly successful NSDL IPO (₹4,011.6 crore OFS) saw overwhelming demand—oversubscription of 41×, with QIBs at 104×, NIIs at 35×, and retail at 7.8×.(turn0news16, turn0search15, turn0news29)
The official allotment status is now finalized on August 4, 2025, and investors can check if they received shares or refunds via multiple online platforms. Expected listing date is August 6, 2025, with strong grey market sentiment suggesting a ~15% premium over the ₹800 IPO price.(turn0news19/turn0search14, turn0news20)
📍 How to Check Your Allotment Status
✅ Registrar Portal — MUFG Intime India (Link Intime)
- Visit the Link Intime IPO status page
- Select NSDL Ltd from the dropdown
- Enter your PAN, Application Number, or DP/Client ID
- Complete captcha → Click Submit/Search
Your allotment result will appear instantly.(turn0news20, turn0news16, turn0search15)
✅ BSE Allotment Page
- Go to the BSE Application Status Check page
- Choose Equity under “Issue Type”
- Select NSDL as the company name
- Enter PAN or Application Number, complete captcha → Submit
- Allotment info will display.(turn0search15, turn0news21)
✅ NSE Bid Status Portal
- Navigate to NSE’s IPO bid verification tool
- Choose Equity & SME IPO bids
- Pick NSDL from the list
- Enter PAN and Application Number, complete captcha → Submit
Status appears on screen.(turn0news9, turn0search15)
After Allotment: Credits & Refunds
| Event | Date |
|---|---|
| ✅ Allotment Finalized | August 4, 2025 (Today) |
| 💳 Refunds / Shares | Credits or refunds by Aug 5 |
| 📈 Listing | August 6, 2025 on BSE & NSE |
Allottees will receive shares in their demat accounts by August 5. For those not allotted, ASBA funds will be refunded by then too.(turn0news20, turn0news16
📊 GMP & Listing Outlook
- Grey Market Premium (GMP): Around ₹124, translating to ~15.5% listing upside on the ₹800 issue price. Estimated listing price ~₹924.(turn0search14, turn0news20)
- GMP earlier ranged higher but cooled to present levels as supply stabilized.(turn0news20, turn0search6)
❓FAQs
❓ When was the allotment finalized?
Allotment was finalized today—August 4, 2025, after the public bidding closed on August 1.(turn0news19, turn0news24)
❓ How soon will I receive shares or refunds?
Shares (for allottees) and refunds (for non-allottees) are expected to be credited by August 5, 2025.(turn0news20, turn0news16)
❓ Which portal is most reliable to check allotment?
Start with Link Intime (registrar). If it’s busy, use BSE or NSE alternatives — all sources provide real-time status.(turn0search0, turn0news20)
❓ Is the grey market premium a guarantee?
No—GMP is speculative sentiment. While ₹124 suggests a 15.5% listing gain, actual listing price may vary (market conditions, investor demand).(turn0search14, turn0news20)
📝 Summary Table
| Query | NSDL IPO Detail |
|---|---|
| 💼 IPO Type | Offer for Sale (OFS) only |
| 💰 Price Band | ₹760–₹800 |
| 📈 Allotment Status | Finalized on Aug 4, 2025 |
| 🧾 Refund / Credit | By Aug 5, 2025 |
| 📅 Listing Date | August 6, 2025 |
NSDL’s IPO has a unique structure—comprising entirely of existing shares, yet executed strongly thanks to high institutional participation and clean financials.
💡 Investor Notes
- If allotted, consider placing a sell order near ₹920–₹925 on listing day, tracking GMP sentiment.
- If unallotted, observe the stock’s first few days of trade and fundamentals before investing. NSDL’s monopoly in Indian depository infra may offer long-term value.
- Keeping alerts on brokerage portals helps track credit status promptly on August 5.
⚠️ Disclaimer
This article is for informational purposes only. Allotment timelines, GMP figures, and procedural steps are sourced from public reports as of August 4, 2025. Past performance is not a guarantee. Consult a SEBI-registered financial advisor before making investment decisions.
